Skip to content

Clinical trials

Mesothelioma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20153
20163
20172
20203
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AbbVie1
Actym Therapeutics, Inc.1
AstraZeneca1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Epizyme, Inc.1
Incyte Biosciences International Sàrl1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma18
Carcinoma, Non-Small-Cell Lung6
Melanoma5
Mesothelioma, Malignant5
Carcinoma, Hepatocellular4
Carcinoma, Renal Cell4
Ovarian Neoplasms4
Stomach Neoplasms4
Carcinoma, Merkel Cell3
Small Cell Lung Carcinoma3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.